Lantus Solution for Injections 100 IU Sanofi

£252.00

Lantus Solution for Injections 100 IU Sanofi represents pharmaceutical-grade insulin glargine formulation for laboratory research applications examining glucose metabolism pathways and cellular uptake mechanisms in controlled experimental settings.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Lantus Solution for Injections 100 IU Sanofi
Lantus Solution for Injections 100 IU Sanofi
£252.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Compound Profile: Lantus Solution for Injections

Lantus Solution for Injections 100 IU Sanofi is a pharmaceutical-grade insulin glargine preparation manufactured by Sanofi for in-vitro research applications. This long-acting synthetic insulin analogue provides researchers with a standardised tool for investigating glucose homeostasis, cellular metabolism, and insulin receptor binding mechanisms in laboratory settings. The formulation offers consistent bioactivity profiles essential for reproducible experimental outcomes. Scientists at Stroid UK Shop utilise insulin preparations to study pancreatic beta-cell function, hepatic glucose production, and peripheral tissue glucose uptake in various metabolic research models.

Laboratory Applications

Research applications encompass diabetes pathophysiology studies, metabolic syndrome investigations, and insulin resistance mechanism analysis. The preparation enables examination of glucose transporter expression, glycogen synthesis pathways, and lipid metabolism regulation in cellular and tissue models. Comparative studies utilise insulin glargine to evaluate novel antidiabetic compounds and investigate insulin sensitising mechanisms. Researchers studying metabolic modulators frequently employ insulin preparations as positive controls in glucose tolerance assessments and insulin signalling pathway research.

Product Specifications

Lantus Solution Technical Data
Parameter Specification
Active ingredient Insulin glargine 100 IU/mL
Manufacturer Sanofi Pharmaceuticals
Formulation Injectable solution
Storage temperature 2-8°C refrigerated
Shelf life Verify with supplier documentation
pH range Approximately 4.0 (acidic formulation)

Advanced research facilities also investigate insulin analogues alongside selective androgen receptor modulators and bioactive peptides to examine metabolic interactions in comprehensive experimental protocols.

Research Compliance

This insulin preparation is supplied exclusively for legitimate in-vitro laboratory research purposes. Not intended for human consumption, therapeutic use, or any application outside accredited research facilities. Researchers must maintain appropriate laboratory safety protocols and regulatory compliance when handling pharmaceutical preparations. Purchase requires institutional affiliation verification and adherence to local research chemical regulations.

Related